A Novel Multi-Antigen Virally Vectored Vaccine against Mycobacterium avium Subspecies paratuberculosis

Tim J. Bull; Sarah C. Gilbert; Saranya Sridhar; Richard Linedale; Nicola Dierkes; Karim Sidi-Boumedine; John Hermon-Taylor

doi:10.1371/journal.pone.0001229

Loading metrics

Open Access

Peer-reviewed

Research Article

A Novel Multi-Antigen Virally Vectored Vaccine against Mycobacterium avium Subspecies paratuberculosis

Tim J. Bull,

Affiliation Department of Cardiovascular Sciences-Surgery, St George's University of London, London, United Kingdom
⨯
Sarah C. Gilbert,

Affiliation Wellcome Trust Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom
⨯
Saranya Sridhar,

Affiliation Wellcome Trust Centre for Human Genetics, Nuffield Department of Medicine, University of Oxford, Oxford, United Kingdom
⨯
Richard Linedale,

Affiliation Department of Cardiovascular Sciences-Surgery, St George's University of London, London, United Kingdom
⨯
Nicola Dierkes,

Affiliation Department of Cardiovascular Sciences-Surgery, St George's University of London, London, United Kingdom
⨯
Karim Sidi-Boumedine,

Affiliation Department of Cardiovascular Sciences-Surgery, St George's University of London, London, United Kingdom
⨯
John Hermon-Taylor

*To whom correspondence should be addressed. E-mail: jhermon@sgul.ac.uk

Affiliation Department of Cardiovascular Sciences-Surgery, St George's University of London, London, United Kingdom
⨯

A Novel Multi-Antigen Virally Vectored Vaccine against Mycobacterium avium Subspecies paratuberculosis

Tim J. Bull,
Sarah C. Gilbert,
Saranya Sridhar,
Richard Linedale,
Nicola Dierkes,
Karim Sidi-Boumedine,
John Hermon-Taylor

Published: November 28, 2007
https://doi.org/10.1371/journal.pone.0001229

Reader Comments

Post a new comment on this article

Posted by NiyazAhmed on 06 Dec 2007 at 17:26 GMT

there is a real need to progress this new therapeutic vaccine to GMP manufacture and approved clinical trials in people infected with the causative pathogens, Mycobacterium avium subsp. paratuberculosis (MAP)

Subject Areas
?

For more information about PLOS Subject Areas, click here.
We want your feedback. Do these Subject Areas make sense for this article? Click the target next to the incorrect Subject Area and let us know. Thanks for your help!

Vaccination and immunization
Is the Subject Area "Vaccination and immunization" applicable to this article?

Thanks for your feedback.
Recombinant vaccines
Is the Subject Area "Recombinant vaccines" applicable to this article?

Thanks for your feedback.
Prophylaxis
Is the Subject Area "Prophylaxis" applicable to this article?

Thanks for your feedback.
Enzyme-linked immunoassays
Is the Subject Area "Enzyme-linked immunoassays" applicable to this article?

Thanks for your feedback.
Spleen
Is the Subject Area "Spleen" applicable to this article?

Thanks for your feedback.
Paratuberculosis
Is the Subject Area "Paratuberculosis" applicable to this article?

Thanks for your feedback.
Vaccines
Is the Subject Area "Vaccines" applicable to this article?

Thanks for your feedback.
Mycobacterium avium complex
Is the Subject Area "Mycobacterium avium complex" applicable to this article?

Thanks for your feedback.

A Novel Multi-Antigen Virally Vectored Vaccine against Mycobacterium avium Subspecies paratuberculosis

A Novel Multi-Antigen Virally Vectored Vaccine against Mycobacterium avium Subspecies paratuberculosis

Reader Comments

Post Your Discussion Comment

Why should this posting be reviewed?

Thank You!

Posted by NiyazAhmed on 06 Dec 2007 at 17:26 GMT